Synlogic   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2014)

Organization Overview

First Clinical Trial
2017
NCT03179878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Synlogic